Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Lovell

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
European Journal of Medicinal Chemistry|December 4, 2016
Structure-based exploration and exploitation of the S<sub>4</sub> subsite of norovirus 3CL protease in the design of potent and permeable inhibitorsAnushka C Galasiti Kankanamalage, Yunjeong Kim, Athri D Rathnayake, et al.
Acta Crystallographica. Section F, Structural Biology Communications|November 27, 2024
Structures of Trichomonas vaginalis macrophage migratory inhibitory factorAruesha Srivastava, Aryana Nair, Omolara C O Dawson, et al.
Protein Science : a Publication of the Protein Society|July 29, 2024
Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsinMatthew W Mahoney, Jonathan Helander, Anoopjit S Kooner, et al.
Journal of Medicinal Chemistry|December 6, 2021
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based StudiesChamandi S Dampalla, Athri D Rathnayake, Krishani Dinali Perera, et al.
Nature Communications|October 14, 2025
Discovery and mechanism of a highly selective, antifungal acetyl-CoA synthetase inhibitorAndrew J Jezewski, Katy M Alden, Jonah Propp, et al.
Oncogene|May 31, 2020
Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancerBruno M Simões, Angélica Santiago-Gómez, Chiara Chiodo, et al.
Molecular Biology of the Cell|December 9, 2020
Costameric integrin and sarcoglycan protein levels are altered in a <i>Drosophila</i> model for Limb-girdle muscular dystrophy type 2HSimranjot Bawa, Samantha Gameros, Kenny Baumann, et al.
Molecular Oncology|October 21, 2019
The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancerThomas Kryza, Nathalie Bock, Scott Lovell, et al.
Journal of Medicinal Chemistry|May 31, 2022
Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like ProteaseChamandi S Dampalla, Athri D Rathnayake, Anushka C Galasiti Kankanamalage, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2006
R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammationSylvia Braselmann, Vanessa Taylor, Haoran Zhao, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
European Journal of Medicinal Chemistry|December 4, 2016
Structure-based exploration and exploitation of the S<sub>4</sub> subsite of norovirus 3CL protease in the design of potent and permeable inhibitorsAnushka C Galasiti Kankanamalage, Yunjeong Kim, Athri D Rathnayake, et al.
Acta Crystallographica. Section F, Structural Biology Communications|November 27, 2024
Structures of Trichomonas vaginalis macrophage migratory inhibitory factorAruesha Srivastava, Aryana Nair, Omolara C O Dawson, et al.
Protein Science : a Publication of the Protein Society|July 29, 2024
Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsinMatthew W Mahoney, Jonathan Helander, Anoopjit S Kooner, et al.
Journal of Medicinal Chemistry|December 6, 2021
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based StudiesChamandi S Dampalla, Athri D Rathnayake, Krishani Dinali Perera, et al.
Nature Communications|October 14, 2025
Discovery and mechanism of a highly selective, antifungal acetyl-CoA synthetase inhibitorAndrew J Jezewski, Katy M Alden, Jonah Propp, et al.
Oncogene|May 31, 2020
Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancerBruno M Simões, Angélica Santiago-Gómez, Chiara Chiodo, et al.
Molecular Biology of the Cell|December 9, 2020
Costameric integrin and sarcoglycan protein levels are altered in a <i>Drosophila</i> model for Limb-girdle muscular dystrophy type 2HSimranjot Bawa, Samantha Gameros, Kenny Baumann, et al.
Molecular Oncology|October 21, 2019
The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancerThomas Kryza, Nathalie Bock, Scott Lovell, et al.
Journal of Medicinal Chemistry|May 31, 2022
Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like ProteaseChamandi S Dampalla, Athri D Rathnayake, Anushka C Galasiti Kankanamalage, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2006
R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammationSylvia Braselmann, Vanessa Taylor, Haoran Zhao, et al.
Pageof 17